Literature DB >> 27813209

A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.

Daniel A Yanes1, Joy L Mosser-Goldfarb1.   

Abstract

Hydroxyurea is a medication with many well-described cutaneous side effects, notably the dermatomyositis-like eruption known as hydroxyurea dermopathy. Although systemic lupus erythematosus has been reported with hydroxyurea use, cutaneous lupus has not. We report a novel case of chronic cutaneous lupus induced by hydroxyurea and propose that this is a side effect that is distinct from hydroxyurea dermopathy.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27813209     DOI： 10.1111/pde.13018

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  3 in total

Review 1.  Drug-induced lupus erythematosus: an update on drugs and mechanisms.

Authors:  Ye He; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-09       Impact factor: 5.006

2.  ISMP Adverse Drug Reactions: Minocycline-Induced Drug Fever Without Skin Rash Lupus Erythematosus-Like Eruption Induced by Hydroxyurea Cardiotoxicity and Fever Induced by Clozapine Denosumab-Induced Hepatotoxicity Severe Cardiotoxicity Induced by Bevacizumab.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2018-02-07

Review 3.  Anticancer treatments and photosensitivity.

Authors:  V Sibaud
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06       Impact factor: 9.228
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.